Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows used in operating activities
Net loss	$ (8,978,129)	$ (8,030,256)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	60,825	63,359
Accretion of discount on convertible debentures	64,101
Accrued expenditures for government grant	23,767
Accrued interest		5,476
Accrue interest expense, convertible debentures	8,716
Accrued interest income, related party	2,550	(886)
Change in fair value of conversion feature liability	(174,930)
Change in fair value of warrant liabilities	16,127	532,429
Change in fair value of bonus rights liability	(9,875)	5,246
Debt issuance costs	354,791
Provision for loan losses	55,000
Impairment of intangible assets	39,166
Share-based compensation	917,153	1,899,429
Shares issued for services	2,273,949
Changes in non-cash operating working capital items:
Prepaid expenses and other current assets	(454,617)	68,761
Accounts payable and accrued liabilities	349,478	(1,312,729)
Net cash used in operating activities	(5,451,927)	(6,769,171)
Cash flows provided by (used in) investing activities
Net cash provided by (used in) investing activities
Cash flows provided by financing activities
Units issued for cash	3,732,469	5,851,148
Exercise of options	1,800	10,500
Exercise of warrants	300,000
Proceeds received from restricted government grant	373,825	201,500
Amounts paid from restricted government grant funds	(357,228)
Issuance of related party note		(55,000)
Proceeds from issuance of convertible debentures	4,545,000
Debt issuance costs	(459,360)
Share issuance costs	(405,753)	(394,736)
Net cash provided by financing activities	7,730,753	5,613,412
Effect of foreign exchange on cash		(19,573)
Change in cash and cash equivalents during the period	2,278,826	(1,175,332)
Cash and cash equivalents, beginning of period	1,494,573	2,083,696
Cash and cash equivalents, end of period	3,773,399	908,364
Cash and cash equivalents consists of:
Demand deposits	3,666,389	706,864
Restricted cash	107,010	201,500
Total cash and cash equivalents	3,773,399	908,364
Supplemental Disclosure
Cash paid for interest	37,754	53,991
Supplemental non-cash disclosures
Reallocation of fair value of share options upon exercise	126,382	676,632
Reclassification of derivative liability for warrants priced with USD per change in functional currency		351,969
Reclassification of derivative liability for warrants priced with CAD per change in functional currency		4,541,545
Reclassification of derivative liability for warrants re-priced from CAD to USD exercise price	3,942,575
Common shares issued for share issuance costs	928,874
Warrants issued for share issuance costs	582,245	117,310
Common shares issued for services	$ 2,273,949